2028 年亚太地区疣治疗市场预测 - COVID-19 影响和按类型划分的区域分析(寻常疣、生殖器疣、扁平疣等);治疗(物理破坏、免疫调节和化学破坏);最终用户(医院、家庭护理、专科诊所等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 148    |    Report Code: TIPRE00025053    |    Category: Life Sciences

Asia Pacific Warts Therapeutics Market

市场介绍

疣是由人乳头瘤病毒(HPV)引起的皮肤生长。 HPV 有 60 多种类型,其中一些容易引起皮肤疣。局部治疗可能会在几周内解决疣问题,并且副作用最小。局部治疗可能并不总是有效。因此,液氮冷冻疗法是一种合适的治疗选择,其治愈率为60%至90%,复发率低于20%至10%。

因此,新产品的开发预计将创造未来几年对疣治疗药物的巨大需求,预计将进一步推动疣治疗市场的发展。

COVID-19 大流行给全球带来了前所未有的挑战。它给世界许多国家的卫生系统带来了巨大压力,并扰乱了包括 HPV 筛查在内的许多服务。 COVID-19 大流行可能会扭转该地区在减少 HPV 负担方面取得的进展。由于经济活动和人口结构的集中,COVID-19 对东北亚的影响是巨大的。尽管疫情阻碍了许多可持续发展目标的进展,甚至逆转了一些成果。该次区域大多数国家的GDP水平相对较低,进一步阻碍了许多医疗保健政策的进展。此外,资源被重新分配给 COVID-19,许多州和地方公共卫生计划已无法维持 COVID-19 之前预防和控制其他传染病的活动水平。有关艾滋病毒、病毒性肝炎、性传播感染和结核病项目的此类负面影响已有报道。人员配备的减少加上诊断能力的下降,导致性传播疾病筛查的短缺,以及由于社交距离要求而进行现场患者护理的能力有限,对市场增长产生了负面影响。

市场概况和动态

亚太地区的疣治疗市场是预计将从 2021 年的 4.15 亿美元增长到 2028 年的 5.415 亿美元;预计2021年至2028年复合年增长率为3.9%。疣是由多种人乳头瘤病毒(HPV)毒株引起的,不同毒株会导致身体不同部位出现疣。健康人接触疣可能会受到感染。而且,尖锐湿疣的复发率很高。根据国家生物技术信息中心 (NCBI) 的数据,约 30% 的疣病例预计会在感染后的前四个月内消退。 HPV 感染会导致宫颈癌,而宫颈癌是女性第四大常见癌症。根据世界卫生组织 (WHO) 的数据,2018 年记录了约 570,000 例新发宫颈癌病例,低收入国家的患病率很高。因此,HPV 感染率的增加导致疣病例增加,而疣的高复发率正在推动疣治疗市场的增长。

 

主要细分市场

从类型来看,寻常疣细分市场在2020年亚太地区疣治疗市场中占据最大份额。就治疗而言,物理破坏细分市场在2020年亚太疣治疗市场中占据最大份额。在最终用户方面,医院细分市场在2020年亚太疣治疗市场中占据最大份额。

 

主要来源和上市公司

<准备本亚太地区疣治疗市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Bausch Health Companies Inc.、Euro Vital Pharma GmbH、Cipla Inc.、Koninklijke Utermöhlen NV、Scholl\'s Wellness Company、Teva Pharmaceutical Industries Ltd、GlaxoSmithKline plc. 和 Novan, Inc.

 

< span>购买报告的理由

  • 了解亚太地区疣治疗市场格局并确定最有可能的细分市场保证丰厚的回报
  • 了解亚太地区疣治疗市场不断变化的竞争格局,保持领先地位
  • 有效规划亚太地区疣治疗领域的并购和合作交易通过识别最有希望销售的细分市场来了解市场
  • 通过对亚太疣治疗市场各个细分市场的市场表现进行敏锐而全面的分析,帮助做出明智的业务决策
  • 获取市场2021-2028年亚太地区各细分市场收入预测

 

亚太地区疣治疗市场细分

 

按类型

  • 寻常疣
  • 生殖器疣
  • 扁平疣
  • 其他

 

通过治疗

  • 物理破坏
  • 冷冻疗法
  • 手术切除
  • 激光治疗
  • 免疫调节
  • 干扰素
  • 类维生素A
  • 化学破坏< /span>
  • 博来霉素
  • 斑蝥素
  • 水杨酸
  • 其他

 

作者< span>最终用户

  • 医院
  • 家庭护理
  • 专科诊所
  • 其他

 

按国家/地区

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太地区其他地区

 

< /p>

提及的公司

  1. Bausch Health Companies Inc.            
  2. Euro Vital Pharma GmbH               
  3. 西普拉公司               
  4. Koninklijke Uterm&oml;hlen NV               
  5. Scholl\'s Wellness Company            
  6. 梯瓦制药工业有限公司                
  7. 葛兰素史克公司。         
  8. 诺万公司

 

 

Asia Pacific Warts Therapeutics Strategic Insights

Strategic insights for Asia Pacific Warts Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-warts-therapeutics-market-strategic-framework.webp
Get more information on this report

Asia Pacific Warts Therapeutics Report Scope

Report Attribute Details
Market size in 2021 US$ 415.0 Million
Market Size by 2028 US$ 541.5 Million
Global CAGR (2021 - 2028) 3.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 类型
  • 普通疣
  • 生殖器疣
  • 扁平疣
By 治疗
  • 物理破坏
  • 免疫调节
  • 化学破坏
By 最终用户
  • 医院
  • 家庭护理
  • 专科诊所
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Bausch Health Companies Inc.
  • Euro Vital Pharma GmbH
  • Cipla Inc.
  • Koninklijke Utermöhlen NV
  • Schols Wellness Company
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Novan, Inc.
  • Get more information on this report

    Asia Pacific Warts Therapeutics Regional Insights

    The regional scope of Asia Pacific Warts Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-warts-therapeutics-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Warts Therapeutics Market

    1. Bausch Health Companies Inc.       
    2. Euro Vital Pharma GmbH                 
    3. Cipla Inc.                 
    4. Koninklijke Utermöhlen NV             
    5. Scholl's Wellness Company             
    6. Teva Pharmaceutical Industries Ltd             
    7. GlaxoSmithKline plc.      
    8. Novan, Inc.

       

                   

    Frequently Asked Questions
    How big is the Asia Pacific Warts Therapeutics Market?

    The Asia Pacific Warts Therapeutics Market is valued at US$ 415.0 Million in 2021, it is projected to reach US$ 541.5 Million by 2028.

    What is the CAGR for Asia Pacific Warts Therapeutics Market by (2021 - 2028)?

    As per our report Asia Pacific Warts Therapeutics Market, the market size is valued at US$ 415.0 Million in 2021, projecting it to reach US$ 541.5 Million by 2028. This translates to a CAGR of approximately 3.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Warts Therapeutics Market report typically cover these key segments-

  • 类型 (普通疣, 生殖器疣, 扁平疣)
  • 治疗 (物理破坏, 免疫调节, 化学破坏)
  • 最终用户 (医院, 家庭护理, 专科诊所)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Warts Therapeutics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Warts Therapeutics Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Warts Therapeutics Market?

    The Asia Pacific Warts Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bausch Health Companies Inc.
  • Euro Vital Pharma GmbH
  • Cipla Inc.
  • Koninklijke Utermöhlen NV
  • Schols Wellness Company
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Novan, Inc.
  • Who should buy this report?

    The Asia Pacific Warts Therapeutics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Warts Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.